ENGNW enGene Therapeutics Inc.: institutional ownership and insider trading

11 funds reported holding $730K of enGene Therapeutics Inc. in their latest 13F filings; in Q2 2026 funds net bought $734K, with 11 new positions and 0 funds selling out; over the last 12 months insiders bought $10.1K and sold $0 on the open market.

ENGNW revenue and earnings

Famous investors holding ENGNW

Largest institutional holders of ENGNW

  1. BVF INC/IL — $274K
  2. Blue Owl Capital Holdings LP — $148K
  3. Caption Management, LLC — $96.7K
  4. LMR Partners LLP — $89.8K
  5. ARISTEIA CAPITAL, L.L.C. — $47.7K
  6. D. E. Shaw & Co., Inc. — $30.3K
  7. MILLENNIUM MANAGEMENT LLC — $20.0K
  8. TORONTO DOMINION BANK (TD, TDBCP) — $9.15K
  9. StoneX Group Inc. (SNEX) — $8.92K
  10. CSS LLC/IL — $4.90K

Recent ENGNW insider trades

5%+ owners

Who owns the most ENGNW stock?

The largest institutional holders of enGene Therapeutics Inc. in the latest 13F filings are BVF INC/IL ($274K), Blue Owl Capital Holdings LP ($148K), Caption Management, LLC ($96.7K).

Are insiders buying or selling ENGNW?

Over the last 12 months insiders bought $10.1K and sold $0 of enGene Therapeutics Inc. stock on the open market (SEC Form 4).

Which famous investors own ENGNW?

D. E. Shaw, Izzy Englander.

All ENGNW 13F holders · All ENGNW insider trades